Methylcobalamin and cyanocobalamin: what the difference is and when it matters

May 29, 2026

One of these two forms of vitamin B12 exists in human cells and the other is a manufacturing convenience. That sounds decisive and mostly is not. Here is what the chemistry establishes, what the evidence does not, and why a formula still has to pick one.

Four forms, one vitamin

Vitamin B12 is a cobalt atom held inside a large ring, with one variable group attached above it. Change that group and the name changes; the rest of the molecule does not.

Form	Group attached to the cobalt	Occurs in human cells?	Where it is met
Methylcobalamin	A methyl group	Yes — an active coenzyme	Supplements; found in plasma
Adenosylcobalamin	An adenosyl group	Yes — an active coenzyme	Supplements; found in tissue
Hydroxocobalamin	A hydroxyl group	Yes, as a transit form	Mainly injections
Cyanocobalamin	A cyanide group	No	Most supplements and fortified foods

Figure 1 One molecule, four detachable hats The corrin ring and its cobalt atom are identical across all four forms. Only the group bound above the cobalt differs, and that group is what the name refers to. A diagram of established cobalamin chemistry.

Where cyanocobalamin comes from

A purification artifact that stuck

Cyanocobalamin is not found in food or in human tissue. It arises during the isolation of B12 from bacterial culture, where cyanide is used in processing and binds tightly to the cobalt.

Why it became the default anyway

Because the same tight bond makes it the most stable of the four. It tolerates light, heat and shelf time better than the coenzyme forms, it is cheaper to manufacture, and it is the form behind most of the last seventy years of clinical use.

That is a genuinely strong position, and any argument against cyanocobalamin has to get past it rather than around it.

What B12 does

In human metabolism it is a cofactor for exactly two enzymes. Not dozens — two.

In the cytosol

Methionine synthase converts homocysteine to methionine, and its cofactor is methylcobalamin. When this reaction runs poorly, homocysteine accumulates.

In the mitochondria

Methylmalonyl-CoA mutase handles a step in the breakdown of certain fats and amino acids, and its cofactor is adenosylcobalamin. When this one runs poorly, methylmalonic acid accumulates.

Those two accumulating compounds are how B12 status is assessed in a laboratory, and they are why the two coenzyme forms are both required rather than interchangeable.

Figure 3 Two enzymes, two compartments, two coenzymes Methionine synthase runs in the cytosol on methylcobalamin; methylmalonyl-CoA mutase runs in the mitochondria on adenosylcobalamin. A supply of only one form would not cover both. A diagram of established human biochemistry.

The step the marketing skips

Everything is processed to a common intermediate

A swallowed cobalamin does not arrive at an enzyme wearing the group it was sold with. Inside the cell, the upper group is stripped off — the methyl, the adenosyl or the cyanide — producing a bare intermediate. Only then is a new group attached, according to which of the two enzymes needs feeding.

Which is why "pre-methylated" is a misleading phrase

It implies a step has been skipped. The processing happens regardless, and a methylcobalamin capsule does not deliver methylcobalamin intact to methionine synthase.

The honest version is narrower: the removal step differs slightly between forms, and the leftover group differs. That is a real difference. It is a much smaller one than "the body has to convert cyanocobalamin" implies, because the body has to convert all of them.

Figure 4 Every form goes through the same doorway All four forms are stripped to a common intermediate inside the cell before either coenzyme is assembled. No oral form bypasses that processing. A diagram of established intracellular cobalamin handling.

The cyanide question, in arithmetic

This is the argument most often made against cyanocobalamin, and it deserves a number rather than a shudder.

Cyanocobalamin has a molecular weight of about 1,355. The cyanide group accounts for about 26 of that — under 2% by mass. A 500 microgram dose therefore carries under 10 micrograms of cyanide, which the body disposes of by an ordinary route.

For most people that is not a meaningful exposure, and saying otherwise would be scaremongering. There are specific clinical situations in which prescribers prefer a different form, and that is a conversation with a clinician rather than a decision made in an aisle.

The figures above are molecular weights, not a trial. It is offered only as a sense of scale, which is why we do not make a safety argument out of it.

Figure 5 Under two per cent of the molecule, by mass The cyanide group weighs about 26 against a molecule of about 1,355. At a 500 microgram dose that is under 10 micrograms. Molecular-weight arithmetic. Not a clinical finding.

Absorption is the larger variable

The efficient route saturates

Most B12 is absorbed through a receptor-mediated system that depends on a stomach protein, and that system handles only a very small quantity per dose. Beyond it, absorption falls back on simple diffusion, which is inefficient.

Which is why label doses look absurd

The Daily Value used on US labels is 2.4 micrograms. A supplement printing 500 micrograms is therefore printing a percentage in the tens of thousands, and doing so deliberately: a large dose is how a small diffusion fraction is made to add up.

Absorption efficiency also falls with age and is affected by some long-term medicines. Those variables move the delivered amount far more than the choice between two upper groups does.

Figure 6 The efficient route runs out; the inefficient one does not Receptor-mediated uptake reaches a ceiling within a very small dose. Everything above that ceiling depends on simple diffusion, which rises slowly and without limit. A chart of established absorption physiology, not plotted from a dataset.

Figure 7 A five-figure percentage is a design decision Against a Daily Value of 2.4 micrograms, a 500 microgram dose prints as a number in the tens of thousands of per cent. The size of the dose is a response to how little is absorbed. Daily Value per federal labelling rules. A panel in the format the rules require.

What is established, and what is not

Claim	Status
Methylcobalamin and adenosylcobalamin are the two coenzyme forms in human metabolism	Established biochemistry
Cyanocobalamin does not occur naturally in the body	Established
All forms are processed intracellularly before use	Established
Cyanocobalamin is the most stable to light and heat	Established
Methylcobalamin is retained differently after a dose	Reported, and we have not read a source we are willing to cite
Methylcobalamin produces better outcomes in healthy adults	Not established — we know of no head-to-head trial that shows it

The last row is the important one. A great deal of copy in this category implies an outcome difference that the published record does not carry, and the implication is usually made by describing the chemistry and letting the reader finish the sentence.

Figure 8 The chemistry is settled; the outcome question is not What each form is, and how the body handles it, is textbook material. Whether one produces a different result in healthy adults is a separate question with a much thinner answer. A summary of the state of the evidence as we read it.

Why a formula would pick one anyway

Three defensible reasons

It is one of the two coenzyme forms the body's enzymes use, which is a reasonable default even though it is stripped and rebuilt like every other form.
The group it carries is a methyl the body can use rather than a cyanide it has to dispose of, however small that cyanide is.
It is a checkable disclosure: the word is printed inside the parenthetical, and a buyer can confirm it in seconds.

One reason that is not defensible

Claiming it works better. Nothing in the record supports that, and a brand that says so is overstating its evidence.

What this looks like on a label

"Vitamin B12 (as methylcobalamin)" or "(as cyanocobalamin)". One row, identical units, one word apart, and no front-of-pack graphic distinguishes them.

It is the same reading skill that separates alpha-GPC from choline bitartrate, and the same one that a proprietary blend defeats — see how to read a Supplement Facts panel in about sixty seconds and what a proprietary blend actually hides.

The checkable version of the question

"Which form is better" cannot be settled from a shelf and, for most people, may not have a large answer. "Which form is in this pack, and did the brand tell me" can be settled in five seconds, and it is the question a label was built to answer.

The logic runs through the choline pathway, where the form question is much better documented — that is set out in what acetylcholine does, and why choline sits upstream of it.

Figure 9 The question a pack can answer Which form is present is printed and verifiable. Which form is superior is a research question that a shelf cannot resolve.

Where we stand

Weal Focus uses methylcobalamin at 500 micrograms, with the form printed in the panel. We chose it for the three reasons above and not for a fourth one we cannot support.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Sources for the claims and figures on this page, with the population studied in each, are on our citations page.